Novo Nordisk enters the chat with launch of cheaper Ozempic copy
Bizcommunity | 20.07.2026 14:32
The medicine, which uses the same semaglutide active ingredient as Ozempic, will launch on 27 July and is registered by the South African Health Products Regulatory Authority (SAHPRA) as the country’s only authorised semaglutide copy, the Danish drugmaker said in a statement.
